Diisopropylethylamine → (2E)-2-(3-chloro-4-methylsulfonylphenyl)-2-cyclopentyloxyimino-N-(3-methyl-1,2,4-thiadiazol-5-yl)acetamide
Reaction equation
[Cl:1][C:2]1[CH:3]=[C:4](/[C:12](=[N:22]\[O:23][CH:24]2[CH2:28][CH2:27][CH2:26][CH2:25]2)/[C:13]([NH:15][C:16]2C=CN(C)[N:17]=2)=[O:14])[CH:5]=[CH:6][C:7]=1[S:8]([CH3:11])(=[O:10])=[O:9].[CH3:29][C:30]1N=C(N)[S:32][N:31]=1.C(N(CC)C(C)C)(C)C>C(#N)C>[Cl:1][C:2]1[CH:3]=[C:4](/[C:12](=[N:22]\[O:23][CH:24]2[CH2:25][CH2:26][CH2:27][CH2:28]2)/[C:13]([NH:15][C:16]2[S:32][N:31]=[C:30]([CH3:29])[N:17]=2)=[O:14])[CH:5]=[CH:6][C:7]=1[S:8]([CH3:11])(=[O:10])=[O:9]Participants
Reactant 3
Product 1
Reagents, catalysts & solvents 1
Procedure
(E)-(3-Chloro-4-methanesulfonyl-phenyl)-cyclopentyloxyimino-acetic (prepared as in Example 1, 96 mg, 0.28 mmol), 3-methyl-[1,2,4]thiadiazol-5-ylamine (32 mg, 0.28 mmol) and N,N-diisopropylethylamine (145 μL, 0.83 mmol) were combined in acetonitrile (1.25 mL) and cooled in an ice bath. O-(7-Azabenzotriazole-1-yl)-N,N,N′N′-tetramethyluronium hexafluorophosphate (106 mg, 0.28 mmol) was added and the ice bath was removed. After stirring 2 h, the reaction mixture was evaporated in vacuo. The residue was treated with saturated aqueous sodium bicarbonate solution (1 mL) and extracted with chloroform (2×3 mL). The combined organic phases were dried over sodium sulfate and evaporated in vacuo. The residue was purified by flash column chromatography (Merck silica gel 60, 40-63 μm; 40% ethyl acetate/hexanes) to afford (E)-2-(3-chloro-4-methanesulfonyl-phenyl)-2-cyclopentyloxyimino-N-(3-methyl-[1,2,4]thiadiazol-5-yl)-acetamide (62 mg, 50%) as a white solid after lyophilization from aqueous acetonitrile: LC-MS (ESI) m/e calcd for C17H19ClN4O4S2 [M+] 442.05, found 443 [M+H+]; H1-NMR (400 MHz, CDCl3) δ ppm 1.67 (m, 4 H, 2×CH2), 1.90 (m, 4 H, 2×CH2), 2.60 (s, 3 H, ArCH3), 3.32 (s, 3 H, SO2CH3), 4.95 (m, 1 H, OCH), 7.60 (dd, Jo=8.3, Jm=1.6 Hz, 1 H, Ar), 7.70 (d, Jm=1.6 Hz, 1 H, Ar), 8.22 (d, Jo=8.3 Hz, 1 H, Ar), 10.35 (s, 1 H, NH).
Workup
- temperaturecooled in an ice bath
- customthe ice bath was removed
- customthe reaction mixture was evaporated in vacuo
- additionThe residue was treated with saturated aqueous sodium bicarbonate solution (1 mL)
- extractionextracted with chloroform (2×3 mL)
- dry with materialThe combined organic phases were dried over sodium sulfate
- customevaporated in vacuo
- customThe residue was purified by flash column chromatography (Merck silica gel 60, 40-63 μm; 40% ethyl acetate/hexanes)
Sources & evidence
- ORD record
- ord-bffe805ea1fb4838bf6154dc42ffefb9
- Source dataset
- uspto-grants-2011_03
- Patent number
- US07902248B2
Reaction notes
Loading…